We are live on ! Find out more
BIOY

GraniteShares YieldBOOST Biotech ETF
BIOY

2 hedge funds and large institutions have $499K invested in GraniteShares YieldBOOST Biotech ETF in 2026 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

71.83% more ownership

Funds ownership: 0% → 71.83% (+72%)

Holders
2
Holders Change
+2
Holders Change %
–
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
+$513K
2
UBS Group
UBS Group
Switzerland
+$24

Top Sellers

No sellers this quarter

BIOY Hedge Fund Activity: Q2 2026 in Review

2 of the 8,331 institutional investors tracked by Wall St. Rank reported a position in GraniteShares YieldBOOST Biotech ETF (BIOY) for Q2 2026, worth a combined $499K.

Buyers outnumbered sellers: 2 funds opened new BIOY positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Jane Street, opening a new position worth an estimated $513K.

  • 2 institutional investors held GraniteShares YieldBOOST Biotech ETF (BIOY) as of Q2 2026, up from 0 in Q1 2026.
  • Funds reported $499K of GraniteShares YieldBOOST Biotech ETF stock for Q2 2026.
  • 2 funds opened new GraniteShares YieldBOOST Biotech ETF positions in Q2 2026 and 0 closed out, a net change of +2 holders.
  • The largest GraniteShares YieldBOOST Biotech ETF buyer in Q2 2026 was Jane Street, an estimated $513K added.

Based on aggregated 13F filings for Q2 2026.